175 related articles for article (PubMed ID: 38091082)
1. [Exocrine meets neuroendocrine: mimickers of pancreatic neuroendocrine neoplasms].
Karamitopoulou-Diamantis E
Pathologie (Heidelb); 2024 Feb; 45(1):42-49. PubMed ID: 38091082
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls.
Konukiewitz B; Jesinghaus M; Kasajima A; Klöppel G
Virchows Arch; 2022 Feb; 480(2):247-257. PubMed ID: 34647171
[TBL] [Abstract][Full Text] [Related]
3. [Neuroendocrine neoplasms of the head and neck].
Konukiewitz B; Agaimy A; Weichert W; Klöppel G
Pathologe; 2018 Feb; 39(1):27-34. PubMed ID: 29313083
[TBL] [Abstract][Full Text] [Related]
4. Non-Ductal Tumors of the Pancreas.
Dhillon J
Monogr Clin Cytol; 2020; 26():92-108. PubMed ID: 32987393
[TBL] [Abstract][Full Text] [Related]
5. Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10.
Notohara K; Hamazaki S; Tsukayama C; Nakamoto S; Kawabata K; Mizobuchi K; Sakamoto K; Okada S
Am J Surg Pathol; 2000 Oct; 24(10):1361-71. PubMed ID: 11023097
[TBL] [Abstract][Full Text] [Related]
6. Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): concepts, issues and a practical diagnostic approach to high-grade (G3) cases.
Singhi AD; Klimstra DS
Histopathology; 2018 Jan; 72(1):168-177. PubMed ID: 29239037
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors.
Simon T; Riemer P; Jarosch A; Detjen K; Di Domenico A; Bormann F; Menne A; Khouja S; Monjé N; Childs LH; Lenze D; Leser U; Rossner F; Morkel M; Blüthgen N; Pavel M; Horst D; Capper D; Marinoni I; Perren A; Mamlouk S; Sers C
Genome Med; 2022 Mar; 14(1):24. PubMed ID: 35227293
[TBL] [Abstract][Full Text] [Related]
8. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
Jiang Y; Xie J; Wang B; Mu Y; Liu P
Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal/non-epithelial mimickers of neuroendocrine neoplasms with a focus on fusion gene-associated and SWI/SNF-deficient tumors.
Kasajima A; Konukiewitz B; Schlitter AM; Weichert W; Bräsen JH; Agaimy A; Klöppel G
Virchows Arch; 2021 Dec; 479(6):1209-1219. PubMed ID: 34350470
[TBL] [Abstract][Full Text] [Related]
10. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
Rindi G; Mete O; Uccella S; Basturk O; La Rosa S; Brosens LAA; Ezzat S; de Herder WW; Klimstra DS; Papotti M; Asa SL
Endocr Pathol; 2022 Mar; 33(1):115-154. PubMed ID: 35294740
[TBL] [Abstract][Full Text] [Related]
11. PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma.
Sangoi AR; Ohgami RS; Pai RK; Beck AH; McKenney JK; Pai RK
Mod Pathol; 2011 Mar; 24(3):412-24. PubMed ID: 20890270
[TBL] [Abstract][Full Text] [Related]
12. Synaptophysin and chromogranin A expression analysis in human tumors.
Uhlig R; Dum D; Gorbokon N; Menz A; Büscheck F; Luebke AM; Hube-Magg C; Hinsch A; Höflmayer D; Fraune C; Möller K; Bernreuther C; Lebok P; Weidemann S; Lennartz M; Jacobsen F; Clauditz TS; Sauter G; Wilczak W; Steurer S; Burandt E; Krech R; Krech T; Marx AH; Simon R; Minner S
Mol Cell Endocrinol; 2022 Sep; 555():111726. PubMed ID: 35921917
[TBL] [Abstract][Full Text] [Related]
13. [Practical application of immunohistochemistry in pancreatic neuroendocrine neoplasms : Tips and pitfalls].
Bräutigam K; Chouchane A; Konukiewitz B; Perren A
Pathologie (Heidelb); 2024 Feb; 45(1):35-41. PubMed ID: 38175232
[TBL] [Abstract][Full Text] [Related]
14. P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms.
Nielsen K; Binderup T; Langer SW; Kjaer A; Knigge P; Grøndahl V; Melchior L; Federspiel B; Knigge U
BMC Cancer; 2020 Jan; 20(1):27. PubMed ID: 31924180
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
Yao W; Wang W; Li G
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic High-Grade Neuroendocrine Neoplasms in the Korean Population: A Multicenter Study.
Kim H; An S; Lee K; Ahn S; Park DY; Kim JH; Kang DW; Kim MJ; Chang MS; Jung ES; Kim JM; Choi YJ; Jin SY; Chang HK; Cho MY; Kang YK; Kang M; Ahn S; Kim YW; Hong SM;
Cancer Res Treat; 2020 Jan; 52(1):263-276. PubMed ID: 31319641
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic neuroendocrine tumor and solid-pseudopapillary neoplasm: Key immunohistochemical profiles for differential diagnosis.
Ohara Y; Oda T; Hashimoto S; Akashi Y; Miyamoto R; Enomoto T; Satomi K; Morishita Y; Ohkohchi N
World J Gastroenterol; 2016 Oct; 22(38):8596-8604. PubMed ID: 27784972
[TBL] [Abstract][Full Text] [Related]
18. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
Kasprzak A; Zabel M; Biczysko W
Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
[TBL] [Abstract][Full Text] [Related]
19. The cytologic and immunohistochemical findings of pancreatic mixed acinar-endocrine carcinoma.
Whitehair R; Stelow EB
Diagn Cytopathol; 2021 Feb; 49(2):287-294. PubMed ID: 33128511
[TBL] [Abstract][Full Text] [Related]
20. Gastric Amphicrine Carcinoma Showing Neuroendocrine and Pancreatic Acinar Cell Differentiation. Lesson from a Challenging Case Opening New Perspectives in the Diagnostic Work-Up of Gastric Neuroendocrine Neoplasms.
Sciarra A; Uccella S; Hiroz P; Fournier I; Soubeyran V; Finzi G; La Rosa S
Endocr Pathol; 2023 Sep; 34(3):349-357. PubMed ID: 37249796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]